OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

RTX Corp (RTX) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

RTX · RTX Corp

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 8 filings · fetched 2026-11-13T19:57:32Z

Recent reported activity

0purchase rows on this page
7sale rows on this page
23matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-30Filed 2026-11-03Williams Dantaya MOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

M Exercise / conversionStock Appreciation Right · Derivative17,000D0DirectForm 4 ↗0001225208-26-008630
2026-10-30Filed 2026-11-03Williams Dantaya MOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

S Sale (market/private)Common Stock · Non-derivative9,071D201.6951DirectForm 4 ↗0001225208-26-008630
2026-10-30Filed 2026-11-03Williams Dantaya MOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

D Other reported codeCommon Stock · Non-derivative7,929D201.62DirectForm 4 ↗0001225208-26-008630
2026-10-30Filed 2026-11-03Williams Dantaya MOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References: F1

M Exercise / conversionCommon Stock · Non-derivative17,000A94.04DirectForm 4 ↗0001225208-26-008630
2026-10-01Filed 2026-10-05Johnson Amy LOfficer · Senior VP and Controller
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit.

F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025.

References: F1, F2

M Exercise / conversionRestricted Stock Units · Derivative84D0DirectForm 4 ↗0001225208-26-008208
2026-10-01Filed 2026-10-05Johnson Amy LOfficer · Senior VP and Controller
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit.

F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025.

References:

F WithholdingCommon Stock · Non-derivative84D185.01DirectForm 4 ↗0001225208-26-008208
2026-10-01Filed 2026-10-05Johnson Amy LOfficer · Senior VP and Controller
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit.

F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025.

References: F1

M Exercise / conversionCommon Stock · Non-derivative84A0DirectForm 4 ↗0001225208-26-008208
2026-10-01Filed 2026-10-05DaSilva Kevin GOfficer · Senior VP and Treasurer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit.

F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025.

References: F1, F2

M Exercise / conversionRestricted Stock Units · Derivative143D0DirectForm 4 ↗0001225208-26-008207
2026-10-01Filed 2026-10-05DaSilva Kevin GOfficer · Senior VP and Treasurer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit.

F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025.

References:

F WithholdingCommon Stock · Non-derivative143D185.01DirectForm 4 ↗0001225208-26-008207
2026-10-01Filed 2026-10-05DaSilva Kevin GOfficer · Senior VP and Treasurer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Time-based restricted stock units (RSUs) that represent the right to receive one share of the Issuer's Common Stock per unit.

F2 Vesting of RSUs and delivery of shares to satisfy federal tax obligations with respect to the RSUs originally awarded on February 6, 2025.

References: F1

M Exercise / conversionCommon Stock · Non-derivative143A0DirectForm 4 ↗0001225208-26-008207
2026-08-18Filed 2026-08-19Maharajh RamsaranOfficer · EVP and General Counsel
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.

F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References: F2

M Exercise / conversionStock Appreciation Right · Derivative20,069D0DirectForm 4 ↗0001225208-26-007206
2026-08-18Filed 2026-08-19Maharajh RamsaranOfficer · EVP and General Counsel
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.

F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References: F1

S Sale (market/private)Common Stock · Non-derivative13,655D223.9153DirectForm 4 ↗0001225208-26-007206
2026-08-18Filed 2026-08-19Maharajh RamsaranOfficer · EVP and General Counsel
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.

F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

D Other reported codeCommon Stock · Non-derivative6,414D224.07DirectForm 4 ↗0001225208-26-007206
2026-08-18Filed 2026-08-19Maharajh RamsaranOfficer · EVP and General Counsel
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $223.86 to $224.09 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.

F2 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

M Exercise / conversionCommon Stock · Non-derivative20,069A71.62DirectForm 4 ↗0001225208-26-007206
2026-07-28Filed 2026-07-28DaSilva Kevin GOfficer · Senior VP and Treasurer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative2,250D216.932DirectForm 4 ↗0001225208-26-006771
2026-07-27Filed 2026-07-28Atkinson Tracy ADirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative2,295D218.0497DirectForm 4 ↗0001225208-26-006772
2026-07-24Filed 2026-07-28Brunk Troy DOfficer · President, Collins Aerospace
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References: F1

M Exercise / conversionStock Appreciation Right · Derivative12,600D0DirectForm 4 ↗0001225208-26-006773
2026-07-24Filed 2026-07-28Brunk Troy DOfficer · President, Collins Aerospace
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

S Sale (market/private)Common Stock · Non-derivative6,746D210.2DirectForm 4 ↗0001225208-26-006773
2026-07-24Filed 2026-07-28Brunk Troy DOfficer · President, Collins Aerospace
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

D Other reported codeCommon Stock · Non-derivative5,854D210.17DirectForm 4 ↗0001225208-26-006773
2026-07-24Filed 2026-07-28Brunk Troy DOfficer · President, Collins Aerospace
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

S Sale (market/private)Common Stock · Non-derivative1,811D210.645DirectForm 4 ↗0001225208-26-006773
2026-07-24Filed 2026-07-28Brunk Troy DOfficer · President, Collins Aerospace
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.

References:

M Exercise / conversionCommon Stock · Non-derivative12,600A97.65DirectForm 4 ↗0001225208-26-006773
2026-07-24Filed 2026-07-28DaSilva Kevin GOfficer · Senior VP and Treasurer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative4,760D213.62DirectForm 4 ↗0001225208-26-006771
2026-07-01Filed 2026-07-06JASPER PHILIP JOfficer · President, Raytheon
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each Restricted Stock Unit (RSU), including dividend equivalents that accrue during the vesting period, represents a contingent right to receive one share of RTX Common Stock. These RSUs vest on the third anniversary of the date of grant.

References: F1

A Award / grantRestricted Stock Units · Derivative20,860A0DirectForm 4 ↗0001225208-26-006517

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.